Pharma news
Americas
Law firm Andrews Kurth has hired litigation attorney Matthew Dowd as a partner in its Washington, DC office. 26 June 2015
Americas
The Life Sciences Law Forum opened today, June 25, with a lively panel on the implications of online technology for innovative companies in the sector, including the knock on effect for intellectual property rights. 25 June 2015
Americas
A group of individuals has reportedly launched a class action lawsuit against Novartis to stop it enforcing a so-called ‘pay-for-delay’ settlement agreement with generic drug maker Sun Pharma centring on leukaemia drug Gleevec. 25 June 2015
Americas
US law firm Nutter McClennen & Fish has boosted its intellectual property team in Boston with the appointment of Patrick Concannon as partner. 24 June 2015
Americas
The US Court of Appeals for the Federal Circuit has affirmed a lower court ruling which said that a reissue patent covering Pfizer’s arthritis drug Celebrex was invalid for obviousness-type double patenting. 24 June 2015
Asia-Pacific
China’s State Intellectual Property Office has rejected Gilead Sciences’s patent application covering its Sovaldi (sofosbuvir) drug after it was challenged by a non-profit group. 23 June 2015
Americas
A US appeals court has for the second time invalidated a patent covering pharmaceutical company Teva’s multiple sclerosis drug Copaxone. 22 June 2015
Pharma
Law firm Pinsent Masons has expanded its Munich office with the hire of Marc Holtorf as partner. 22 June 2015
Americas
US law firm Honigman Miller Schwartz and Cohn has hired two intellectual property lawyers as partners. 19 June 2015
Americas
On day three of the BIO International Convention, LSIPR spoke to Kevin Noonan and Donald Zuhn, partners at law firm McDonnell Boehnen Hulbert & Berghoff and authors of the Patent Docs blog, about the possible impact of the Federal Circuit’s Ariosa v Sequenom decision on the life sciences industry. 18 June 2015